go 6976 has been researched along with Leucocythaemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshida, A | 1 |
| Ookura, M | 1 |
| Zokumasu, K | 1 |
| Ueda, T | 1 |
| Kelly, ML | 1 |
| Tang, Y | 1 |
| Rosensweig, N | 1 |
| Clejan, S | 1 |
| Beckman, BS | 1 |
2 other studies available for go 6976 and Leucocythaemia
| Article | Year |
|---|---|
Gö6976, a FLT3 kinase inhibitor, exerts potent cytotoxic activity against acute leukemia via inhibition of survivin and MCL-1.
Topics: Acute Disease; Apoptosis; Carbazoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Resp | 2014 |
Granulocyte-macrophage colony-stimulating factor rescues TF-1 leukemia cells from ionizing radiation-induced apoptosis through a pathway mediated by protein kinase Calpha.
Topics: Apoptosis; Carbazoles; Enzyme Inhibitors; Granulocyte Colony-Stimulating Factor; Humans; Indoles; Le | 1998 |